TRAW vs WMB · rev $2.8M vs P/E 31, rev $6.08B
Traws Pharma Inc (TRAW) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Traws Pharma Inc (TRAW) is a biotechnology company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
Latest reported TRAW revenue for 2025-09-30 was $2.8M. Net income was $16.6M. Revenue was up 2.1% from 2025-06-30 to 2025-09-30. TRAW currently screens at market cap $12.1M.
Latest reported WMB revenue for 2026-06-30 was $6.08B. Net income was $1.69B. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
TRAW currently screens at market cap $12.1M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the TRAW and WMB stock pages for the full models.
Not investment advice.